SCHEMBL9809517

SCHEMBL9809517

C#CCCC(=O)C(O[Si](C)(C)C)(c1ccccc1)C1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
POLB P06746 1/20 0.38
CHRM2 P08172 7/20 0.38
CHRM1 P11229 7/20 0.38
CHRM4 P08173 5/20 0.38
CHRM3 P20309 5/20 0.38
KCNH2 Q12809 3/20 0.38
CYP2C19 P33261 2/20 0.38
SLC6A3 Q01959 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
PKM P14618 1/20 0.38
NFKB1 P19838 1/20 0.38
THPO P40225 1/20 0.38
ABCB11 O95342 1/20 0.38
ESR1 P03372 1/20 0.38
CHRM5 P08912 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9809542 0.84 KEAP1 (0.40) KEAP1NFE2L2POLBCHRM2CHRM1
SCHEMBL9809468 0.81 KEAP1 (0.46) KEAP1NFE2L2POLBCHRM2CHRM1
SCHEMBL9809488 0.81 KEAP1 (0.46) KEAP1NFE2L2POLBCHRM2CHRM1
SCHEMBL9618819 0.78 KEAP1 (0.57) KEAP1NFE2L2POLBCHRM2CHRM1
SCHEMBL5948356 0.69 SSTR4 (0.40) KEAP1NFE2L2
SCHEMBL5948488 0.69 SSTR4 (0.40) KEAP1NFE2L2
SCHEMBL9619021 0.68 CHRM2 (0.58) POLBCHRM2CHRM1CHRM4CHRM3
SCHEMBL2763726 0.67 KEAP1 (0.56) KEAP1NFE2L2POLBCHRM2CHRM1
SCHEMBL7919594 0.67 KEAP1 (0.56) KEAP1NFE2L2POLBCHRM2CHRM1
SCHEMBL7276873 0.67 KEAP1 (0.56) KEAP1NFE2L2POLBCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5036107-A Treatment of neurogenic bladder disorders MARION MERRELL DOW INC. (US) 1991-07-30 US disclosed